Simplified rules for advertising medicinal products – less paper, more digital solutions
New provisions on the advertising of medicinal products directed at healthcare professionals are now in force. Under the adopted amendments, information on a medicinal product may also be provided electronically, using a QR code or Data Matrix code.
On 22 July 2026, the Regulation of the Minister of Health of 3 July 2026 amending the Regulation on the advertising of medicinal products (Journal of Laws, item 910) entered into force. The new regulation introduces a key change concerning the advertising of medicinal products directed at people authorized to issue prescriptions or trading in medicinal products.
Previously, when advertising medicinal products to healthcare professionals, marketing authorization holders were required to provide, in physical form (as printed information brochures), quite an extensive set of details on the medicinal product being advertised, including:
- the name of the medicinal product and its common name;
- the qualitative and quantitative composition in terms of active substances and those excipients which are essential for the proper use of the medicinal product;
- the pharmaceutical form;
- the therapeutic indication or indications;
- the dosage and method of administration;
- contraindications;
- special warnings and precautions for use;
- adverse reactions;
- the identity of the marketing authorization holder;
- the marketing authorization number and the name of the authority that issued it;
- information on the assigned classification for supply and, in the case of medicinal products listed as reimbursable, the official retail price and the maximum amount of payment contribution made by the patient;
- in the case of a veterinary medicinal product authorized for use in animals whose tissues or products may be intended for human consumption, the withdrawal period.
The amendment also states the means of providing this information:
- electronically, including on an electronic storage medium;
- by providing a web address or an image code containing a hyperlink (including a QR code or Data Matrix code) directing the recipient to a website or a platform using digital solutions, operated by the marketing authorization holder or by an entity acting on its behalf, on which the required information on the medicinal product has been made available.